LeafNLP Demos
Back to explore

Report #2865234

Received Oct 13, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
38 yrs
State
TN
Recovered
Unknown
Vaccinated
Sep 29, 2025
Onset
Sep 29, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (ENGERIX-B)GLAXOSMITHKLINE BIOLOGICALS347XP4—

Symptoms (1)

Underdose

Symptom narrative

Maladministration of Pediatric Dose on an Adult Patient - Inappropriate Dose Administered; Maladministration of Pediatric Dose on an Adult Patient - Inappropriate Dose Administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of underdose in a 38-year-old female patient who received HBV (Engerix B pediatric) (batch number 47XP4, expiry date 16-JUL-2026) for prophylaxis. Previously administered products included Engerix B (received first dose of Engerix B on an unknown date) and Engerix B (received 2nd dose of Engerix B on an unknown date). On 29-SEP-2025, the patient received the 3rd dose of Engerix B pediatric. On 29-SEP-2025, an unknown time after receiving Engerix B pediatric, the patient experienced underdose (Verbatim: Maladministration of Pediatric Dose on an Adult Patient - Inappropriate Dose Administered) and adult use of a child product (Verbatim: Maladministration of Pediatric Dose on an Adult Patient - Inappropriate Dose Administered). The outcome of the underdose and adult use of a child product were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 29-SEP-2025 The registered pharmacist called to ask about vaccination schedule advise after the maladministration of a pediatric dose on an adult patient. This was intended to be the third dose on this patient vaccination schedule.